Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Sorensen, Eisner 2012)
Kidney disease, especially with dialysis
(1) WEGOVY tablets are indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse CV events (CV death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established CV disease and either obesity or overweight
2020 Dec 9
Clinical trials have provided us with some promising results, with patients attaining an average weight loss ranging from 8-15% of their body weight over several months
US$ 20.43
US$ 25.95
US$ 20.62
